Li, Yumei
Xu, Jianfeng
Chen, Chaorong
Lu, Zhenhai
Wan, Desen
Li, Diange
Li, Jason S.
Sorg, Allison J.
Roberts, Curt C.
Mahajan, Shivani
Gallant, Maxime A.
Pinkoviezky, Itai
Cui, Ya
Taggart, David J.
Funding for this research was provided by:
UC Irvine Setup fund
Grace B. Bell Endowed Chair fund
George E. Hewitt Foundation for Medical Research
Article History
Received: 9 May 2023
Accepted: 22 December 2023
First Online: 16 January 2024
Declarations
:
: All specimen collection protocols were approved by the Advarra Institutional Review Board (Pro00025115) and Sun Yat-sen University Cancer Center Institutional Review Board (B2019-068-Y02). For all three cohorts, informed consent was obtained from all patients in accordance with the Declaration of Helsinki Ethical Principles for medical research involving human subjects.
: Not applicable.
: Wei Li is a consultant for Helio Genomics and ChosenMed. Jianfeng Xu, Allison J. Sorg, Curt C. Roberts, Shivani Mahajan, Maxime A. Gallant, and David J. Taggart are employees of Helio Genomics. Diange Li is an employee of Guangzhou Youze Biological Pharmaceutical Technology Company Ltd. The remaining authors declare that they do not have any competing interests.